Pregnancy in the woman with epilepsy: Maternal and fetal outcomes

Seminars in Neurology

Volumn 22, Issue 3, 2002, Pages 299-307

  Pennell, Page B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticonvulsants; Epilepsy; Pregnancy; Teratogenesis; Women

Indexed keywords

AMOBARBITAL; ANTICONVULSIVE AGENT; CARBAMAZEPINE; DIAZEPAM; ETHOSUXIMIDE; METHYLPHENOBARBITAL; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; VIGABATRIN; VITAMIN K GROUP;

CLEFT LIP; CLEFT PALATE; COGNITIVE DEFECT; CONGENITAL HEART MALFORMATION; DELIVERY; DISEASE ASSOCIATION; DRUG MECHANISM; EPILEPSY; FEMALE; FETUS MALFORMATION; FETUS OUTCOME; HUMAN; HYPOXIA; INFANT MORTALITY; INTRAUTERINE GROWTH RETARDATION; LABOR; MATERNAL CARE; MICROCEPHALY; NEONATAL HEMORRHAGE; NEURAL TUBE DEFECT; PREGNANCY; PRENATAL SCREENING; PRIORITY JOURNAL; PUERPERIUM; REVIEW; TERATOGENESIS; VITAMIN SUPPLEMENTATION;

ANTICONVULSANTS; DELIVERY, OBSTETRIC; EPILEPSY; FEMALE; FETAL DISEASES; FETUS; HUMANS; LABOR, OBSTETRIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; RISK FACTORS; SEIZURES; WOMEN'S HEALTH;

EID: 0036765510     PISSN: 02718235     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2002-36649     Document Type: Review

References (76)

1. Yerby MS. Quality of life, epilepsy advances, and the evolving role of anticonvulsants in women with epilepsy. Neurology 2000;55(5 suppl 1):S21-S31; discussion S54-S58
2. Janz D, Schmidt D. Anti-epileptic drugs and failure of oral contraceptives [letter]. Lancet 1974;1:1113
3. Guberman A. Hormonal contraception and epilepsy. Neurology 1999;53(suppl 1):S38-S40
4. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice parameter: Management issues for women with epilepsy (summary statement). Neurology 1998;51:944-948
5. Morrell MJ, Sarto GE, Shafer PO, Borda EA, Herzog A, Callanan M. Health issues for women with epilepsy: A descriptive survey to assess knowledge and awareness among healthcare providers. J Womens Health Gend Based Med 2000;9:959-965
6. Krauss G, Brandt J, Campbell M, Plate C, Summerfield M. Antiepileptic medication and oral contraceptive interactions: A national survey of neurologists and obstetricians. Neurology 1996;46:1534-1539
7. Crawford P, Lee P. Gender differences in management of epilepsy: What women are hearing. Seizure 1999;8:135-139
8. Seale C, Morrell M, Nelson L, Druzin M. Analysis of prenatal and gestational care given to women with epilepsy. Neurology 1998;51:1039-1045
9. Fairgrieve SD, Jackson M, Jonas P, et al. Population based, prospective study of the care of women with epilepsy in pregnancy. Br Med J 2000;321:674-675
10. Devinsky O, Yerby M. Women with epilepsy. Neurol Clin 1994;12:479-495
11. Cantrell D. Epilepsy and pregnancy: A study of seizure frequency and patient demographics. Epilepsia 1997;38(suppl 8):231
12. Yerby M, Collins S. Pregnancy and the mother. In: Engel J, Pedley T, eds. Epilepsy, a Comprehensive Textbook. Philadelphia: Lippincott-Raven; 1997:2027-2035
13. Schmidt D, Canger R, Avanzini G, et al. Change of seizure frequency in pregnant epileptic women. J Neurol Neurosurg Psychiatry 1983;46:751-755
14. Stumpf D, Frost M. Seizures, anticonvulsants, and pregnancy. Am J Dis Child 1978;132:746-748
15. Zahn CA, Morrell MJ, Collins SD, Labiner DM, Yerby MS. Management issues for women with epilepsy: A review of the literature. Neurology 1998;51:949-956
16. Teramo K, Hiilesmaa V. Pregnancy and fetal complications in epileptic pregnancies: Review of the literature. In: Janz D, Bossi L, Dam M, eds. Epilepsy, Pregnancy and the Child. New York: Raven Press; 1982:53-59
17. Teramo K, Hiilesmaa V, Bardy A, et al. Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med 1979;7:3-5
18. Lindhout D, Meinardi H, Meijer J, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy paralleled by changes in pattern of malformations. Neurology 1992;42(suppl 5):94-110
19. Samrén E, van Duijn C, Koch S, et al. Maternal use of antiepileptic drugs and the risk of major congenital malformations: A joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia 1997;38:981-990
20. Nei M, Daly S, Liporace J. A maternal complex partial seizure in labor can affect fetal heart rate. Neurology 1998;51:904-906
21. Yerby M, Devinsky O. Epilepsy and pregnancy. In: Devinsky O, Feldmann E, Hainline B, eds. Advances in Neurology: Neurological Complications of Pregnancy. New York: Raven Press; 1994:45-63
22. Pearlman M, Tintinalli J, Lorenz R. Blunt trauma during pregnancy. N Engl J Med 1990;323:1609-1613
23. Pennell P, Gleba J, Clements S. Antiepileptic drug monitoring during pregnancy in women with epilepsy. Epilepsia 2000;41(suppl 7):200
24. Ohman I, Vitols S, Tomson T. Lamotrigine in pregnancy: Pharmacokinetics during delivery, in the neonate and during lactation. Epilepsia 2000;41:709-713
25. Yerby MS. The use of anticonvulsants during pregnancy. Semin Perinatol 2001;25:153-158
26. Sathanandar S, Blesi K, Tran T, Leppik I. Lamotrigine clearance increases markedly during pregnancy. Epilepsia 2000;41(suppl 7):246
27. Levy R, Yerby M. Effects of pregnancy on antiepileptic drug utilization. Epilepsia 1985;26(suppl 1):S52-S57
28. Yerby M, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 1985;26:631-635
29. Hvas C, Henriksen T, Ostergaard J, Dam M. Epilepsy and pregnancy: Effect of antiepileptic drugs and lifestyle on birth-weight. Br J Obstet Gynaecol 2000;107:896-902
30. Yerby M, Collins S. Teratogenicity of antiepileptic drugs. In: Engel J, Pedley T, eds. Epilepsy, a Comprehensive Textbook. Philadelphia: Lippincott-Raven; 1997:1195-1203
31. Gilmore J, Pennell PB, Stern BJ. Medication use during pregnancy for neurologic conditions. In: Evans R, ed. Neurologic Clinics: Iatrogenic Disorders. Philadelphia: WB Saunders; 1998:189-206
32. Arpino C, Brescianini S, Robert E, et al. Teratogenic effects of antiepileptic drugs: Use of an international database on malformations and drug exposure (MADRE). Epilepsia 2000;41:1436-1443
33. Wide K, Winbladh B, Tomson T, Kallen B. Body dimensions of infants exposed to antiepileptic drugs in utero: Observations spanning 25 years. Epilepsia 2000;41:854-861
34. Morrell M. Guidelines for the care of women with epilepsy. Neurology 1998;51(suppl 5):S21-S27
35. Kaneko S, Battino D, Andermann E, et al. Congenital malformations due to antiepileptic drugs. Epilepsy Res 1999;33:145-158
36. Lindhout D, Omtzigt J, Cornel M. Spectrum of neural-tube defects in 34 infants perinatally exposed to antiepileptic drugs. Neurology 1992;42(suppl 5):111-118
37. Rosa F. Spina bifida in infants of women treated with carbamazepine during pregnancy. N Engl J Med 1991;324:674-677
38. Lindhout D, Schmidt D. In-utero exposure to valproate and neural tube defects. Lancet 1986;2:1392-1393
39. Samrén E, van Duijn C, Christiaens G, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999;46:739-746
40. Canger R, Battino D, Canevini MP, et al. Malformations in offspring of women with epilepsy: A prospective study. Epilepsia 1999;40:1231-1236
41. Yerby M, Cawthon M. Fetal death, malformations and infant mortality in infants of mothers with epilepsy. Epilepsia 1996;37(suppl 5):98
42. Howe A, Oakes D, Woodman P, Webster W. Prothrombin and PIVKA-II levels in cord blood from newborn exposed to anticonvulsants during pregnancy. Epilepsia 1999;40:980-984
43. Srinivasan G, Seeler RA, Tiruvury A, et al. Maternal anticonvulsant therapy and hemorrhagic disease of the newborn. Obstet Gynecol 1982;59:250-252
44. Nelson KB, Ellenber JH. Maternal seizure disorder, outcomes of pregnancy, and neurologic abnormalities in the children. Neurology 1982;32:1247-1254
45. Ganström M, Gaily E. Psychomotor development in children of mothers with epilepsy. Neurology 1992;42(suppl 5):144-148
46. Leonard G, Andermann E, Ptito A. Cognitive effects of antiepileptic drug therapy during pregnancy on school-age offspring. Epilepsia 1997;38(suppl 3):170
47. Meador K. Cognitive effects of epilepsy and of antiepileptic medications. In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practice. 3rd Ed. Philadelphia: Williams & Wilkins; 2001:1215-1226
48. Leavitt A, Yerby M, Robinson N, Sells C, Erickson D. Epilepsy in pregnancy: Developmental outcome of offspring at 12 months. Neurology 1992;42(4 suppl 5):141-143
49. Adab N, Jacoby A, Smith D, Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2001;70:15-21
50. Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh J. Fetal valproate syndrome and autism: Additional evidence of an association. Dev Med Child Neurol 2001;43:202-206
51. Koch S, Titze K, Zimmerman R, Schroder M, Lehmkuhl U, Rauh H. Long-term neuropsychological consequences of maternal epilepsy and anticonvulsant treatment during pregnancy for school-age children and adolescents. Epilepsia 1999;40:1237-1243
52. Reinisch J, Sanders S, Mortensen E, Rubin D. In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 1995;724:1518-1525
53. Vanoverloop D, Schnell R, Harvey E, Holmes L. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol 1992;14:329-335
54. Battino D, Kaneko S, Andermann E, et al. Intrauterine growth in the offspring of epileptic women: A prospective multicenter study. Epilepsy Res 1999;36:53-60
55. Annegers J, Hauser W, Elveback L, Anderson V, Kurland L. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int J Epidemiol 1978;7:241-247
56. Ottman R, Annegers J, Hauser W, Kurland L. Higher risk of seizures in offspring of mothers than fathers with epilepsy. Am J Hum Genet 1988;43:357-364
57. Holmes LB, Harvey EA, Coull BA, et al. The teratogenicity of anticonvulsant drugs. N Engl J Med 2001;344:1132-1138
58. Holmes LB, Rosenberger PB, Harvey EA, Khoshbin S, Ryan L. Intelligence and physical features of children of women with epilepsy. Teratology 2000;61:196-202
59. Delgado-Escueta A, Janz D. Consensus guidelines: Preconception counseling, management, and care of the pregnant woman with epilepsy. Neurology 1992;42:149-160
60. Holmes L, Lieberman E. Report of first positive findings from hospital-based AED pregnancy registry. Teratology 2001;63:250
61. GlaxoSmithKline. Lamotrigine Pregnancy Registry, Interim Report, 9/1/92-3/30/01; 2001
62. Dansky L, Rosenblatt D, Andermann E. Mechanisms of teratogenesis: Folic acid and antiepileptic therapy. Neurology 1992;42:32-42
63. Wegner C, Nau H. Alteration of embryonic folate metabolism by valproic acid during organogenesis: Implications for mechanisms of teratogenesis. Neurology 1992;42(suppl 5):17-24
64. Botto L, Moore C, Khoury M, Erickson J. Medical progress: Neural-tube defects. N Engl J Med 1999;341:1509-1519
65. MRC Vitamin Study Research Group. Prevention of neuraltube defects: Results of the Medical Research Council Vitamin Study. Lancet 1991;338:131-137
66. Hall J, Solehdin F. Folic acid for the prevention of congenital anomalies. Eur J Pediatr 1998;157:445-450
67. Crawford P. CPD-education and self-assessment: Epilepsy and pregnancy. Seizure 2001;10:212-219
68. American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy. ACOG Education Bulletin 1996;No 231
69. Buehler BA, Rao V, Finnell RH. Biochemical and molecular teratology of fetal hydantoin syndrome. Pediatr Neurogenet 1994;12:741-748
70. Pschirrer E, Monga M. Seizure disorders in pregnancy. Obstet Gynecol Clin 2001;28:601-611
71. Malone F, D'Alton M. Drugs in pregnancy: Anticonvulsants. Semin Perinatol 1997;21:114-123
72. Committee on Educational Bulletins of the American College of Obstetricians and Gynecologists. Seizure disorders in pregnancy. Int J Gynecol Obstet 1997;56:279-286
73. Krauer B, Krauer F. Drug kinetics in pregnancy. Clin Pharmacokinet 1977;2:167-181
74. Fox C, Betts T. How much risk does a woman with active epilepsy pose to her newborn child in the puerperium? A pilot study. Seizure 1999;86:367-369
75. Hale T. Medications and Mothers' Milk. 8th Ed. Amarillo, TX: Pharmasoft Medical Publishing; 1999
76. Moore K. The Developing Human: Clinically Oriented Embryology. 4th ed. Philadelphia: WB Saunders; 1988